Lenvatinib Plus Everolimus (Renal Cell Carcinoma)
Nivolumab + Ipilimumab (Renal Cell Carcinoma)
Cabozantinib (Renal Cell Carcinoma)
NCCN Guidelines for Patients®
Kidney Cancer Association
NCCN Guidelines for Patients With Kidney Cancer
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic